72 related articles for article (PubMed ID: 27654702)
1. Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer.
Jagadeeshan S; Venkatraman G; Rayala SK
Expert Opin Ther Targets; 2016 Nov; 20(11):1283-1285. PubMed ID: 27654702
[No Abstract] [Full Text] [Related]
2. The role of p21-activated kinases in pancreatic cancer.
Yeo D; He H; Baldwin GS; Nikfarjam M
Pancreas; 2015 Apr; 44(3):363-9. PubMed ID: 25760284
[TBL] [Abstract][Full Text] [Related]
3. PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition.
Zhou W; Jubb AM; Lyle K; Xiao Q; Ong CC; Desai R; Fu L; Gnad F; Song Q; Haverty PM; Aust D; Grützmann R; Romero M; Totpal K; Neve RM; Yan Y; Forrest WF; Wang Y; Raja R; Pilarsky C; de Jesus-Acosta A; Belvin M; Friedman LS; Merchant M; Jaffee EM; Zheng L; Koeppen H; Hoeflich KP
J Pathol; 2014 Dec; 234(4):502-13. PubMed ID: 25074413
[TBL] [Abstract][Full Text] [Related]
4. Targeting PAK1.
Semenova G; Chernoff J
Biochem Soc Trans; 2017 Feb; 45(1):79-88. PubMed ID: 28202661
[TBL] [Abstract][Full Text] [Related]
5. p21-activated kinase 1 determines stem-like phenotype and sunitinib resistance via NF-κB/IL-6 activation in renal cell carcinoma.
Zhu Y; Liu H; Xu L; An H; Liu W; Liu Y; Lin Z; Xu J
Cell Death Dis; 2015 Feb; 6(2):e1637. PubMed ID: 25675297
[TBL] [Abstract][Full Text] [Related]
6. [Computer-aided prediction and molecular mechanism investigation of active components in compound Kushen injection inhibiting p21-activated kinase 1].
Lin L; Chang J; Tian Y; Chen J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Apr; 41(2):313-320. PubMed ID: 38686412
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of group 1 p21-activated kinases suppresses pancreatic stellate cell activation and increases survival of mice with pancreatic cancer.
Yeo D; Phillips P; Baldwin GS; He H; Nikfarjam M
Int J Cancer; 2017 May; 140(9):2101-2111. PubMed ID: 28109008
[TBL] [Abstract][Full Text] [Related]
8. Old drug new tricks: Chlorhexidine acts as a potential allosteric inhibitor toward PAK1.
Huang HW; Zhang XY; Song PL; Jiang HL; Li W; Wang PL; Wang J; Liu FN
Biochem Biophys Res Commun; 2018 Jan; 495(1):728-732. PubMed ID: 29146188
[TBL] [Abstract][Full Text] [Related]
9. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer effect of novel PAK1 inhibitor via induction of PUMA-mediated cell death and p21-mediated cell cycle arrest.
Woo TG; Yoon MH; Hong SD; Choi J; Ha NC; Sun H; Park BJ
Oncotarget; 2017 Apr; 8(14):23690-23701. PubMed ID: 28423593
[TBL] [Abstract][Full Text] [Related]
11. From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapy.
Maruta H; Ahn MR
Eur J Med Chem; 2017 Dec; 142():229-243. PubMed ID: 28814374
[TBL] [Abstract][Full Text] [Related]
12. PAK4 pathway as a potential therapeutic target in pancreatic cancer.
Thillai K; Sarker D; Wells C
Future Oncol; 2018 Mar; 14(7):579-582. PubMed ID: 29508632
[No Abstract] [Full Text] [Related]
13. Prognostic value of p21-activated kinase 4 in resected pancreatic cancer.
Park S; Kim JW; Kim H; Kim JW; Kim YJ; Lee KW; Kim JH; Kim JH; Hwang JH; Choi YR; Cho JY; Yoon YS; Han HS
APMIS; 2017 Aug; 125(8):699-707. PubMed ID: 28556956
[TBL] [Abstract][Full Text] [Related]
14. N-acetylglucosaminyltransferase V confers hepatoma cells with resistance to anoikis through EGFR/PAK1 activation.
Liu J; Liu H; Zhang W; Wu Q; Liu W; Liu Y; Pan D; Xu J; Gu J
Glycobiology; 2013 Sep; 23(9):1097-109. PubMed ID: 23811795
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological signature of p21-activated kinase 1 in prostate cancer and its regulation of proliferation and autophagy via the mTOR signaling pathway.
Wang Z; Jia G; Li Y; Liu J; Luo J; Zhang J; Xu G; Chen G
Oncotarget; 2017 Apr; 8(14):22563-22580. PubMed ID: 28186966
[TBL] [Abstract][Full Text] [Related]
16. Cloning and functional characterization of human Pak1 promoter by steroid hormones.
Raghavan S; Venkatraman G; Rayala SK
Gene; 2018 Mar; 646():120-128. PubMed ID: 29274909
[TBL] [Abstract][Full Text] [Related]
17. P21-activated protein kinase 1 is overexpressed in gastric cancer and induces cancer metastasis.
Li LH; Luo Q; Zheng MH; Pan C; Wu GY; Lu YZ; Feng B; Chen XH; Liu BY
Oncol Rep; 2012 May; 27(5):1435-42. PubMed ID: 22293972
[TBL] [Abstract][Full Text] [Related]
18. 1,2,3-Triazolyl ester of Ketorolac: A "Click Chemistry"-based highly potent PAK1-blocking cancer-killer.
Nguyen BCQ; Takahashi H; Uto Y; Shahinozzaman MD; Tawata S; Maruta H
Eur J Med Chem; 2017 Jan; 126():270-276. PubMed ID: 27889630
[TBL] [Abstract][Full Text] [Related]
19. Potential role of p21 Activated Kinase 1 (PAK1) in the invasion and motility of oral cancer cells.
Parvathy M; Sreeja S; Kumar R; Pillai MR
BMC Cancer; 2016 May; 16 Suppl 1(Suppl 1):293. PubMed ID: 27229476
[TBL] [Abstract][Full Text] [Related]
20. P21-activated protein kinase 1 induces colorectal cancer metastasis involving ERK activation and phosphorylation of FAK at Ser-910.
Li LH; Zheng MH; Luo Q; Ye Q; Feng B; Lu AG; Wang ML; Chen XH; Su LP; Liu BY
Int J Oncol; 2010 Oct; 37(4):951-62. PubMed ID: 20811717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
